COVID-19 Vaccination Is Safe and Effective in Patients With Inflammatory Bowel Disease: Analysis of a Large Multi-institutional Research Network in the United States

Gastroenterology. 2021 Oct;161(4):1336-1339.e3. doi: 10.1053/j.gastro.2021.06.014. Epub 2021 Jun 15.
No abstract available

Keywords: COVID-19; Crohn's Disease; Inflammatory Bowel Disease; Ulcerative Colitis; Vaccination.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Biological Products / therapeutic use
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines / administration & dosage*
  • COVID-19 Vaccines / adverse effects
  • Colitis, Ulcerative / diagnosis
  • Colitis, Ulcerative / drug therapy*
  • Colitis, Ulcerative / immunology
  • Crohn Disease / diagnosis
  • Crohn Disease / drug therapy*
  • Crohn Disease / immunology
  • Electronic Health Records
  • Female
  • Gastrointestinal Agents / adverse effects
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Steroids / therapeutic use
  • Time Factors
  • Treatment Outcome
  • United States
  • Vaccination* / adverse effects

Substances

  • Biological Products
  • COVID-19 Vaccines
  • Gastrointestinal Agents
  • Immunosuppressive Agents
  • Steroids